In our research, our findings revealed the overexpression and unfavorable prognostic role of 14-3-3 zeta in BrCa, which is consistent with the role of 14-3-3 zeta as a tumor promoter according to previous publications. The gene discussed is YWHAZ; the disease is invasive breast carcinoma.